RSLBF
RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 1.55 | $289M | $110M |
| 2025 Q4 | 2.00 | $375M | $111M |
| 2025 Q3 | 2.09 | $332M | -$63M |
| 2025 Q2 | 0.90 | $305M | $18M |
| 2025 Q1 | 1.66 | $332M | $85M |
| 2024 Q4 | 1.75 | $323M | $42M |
| 2024 Q3 | 1.32 | $293M | $22M |
| 2024 Q2 | 1.79 | $319M | $97M |